Authors













Jana Pöttgen, PhD

Latest:

Rehabilitation in Multiple Sclerosis (RiMS) Network Is Key to the World Health Organization’s Rehabilitation 2030: A Call for Action for People With Multiple Sclerosis

This editorial maps RiMS’s activities and aligns it with the WHO’s 10 priority areas, assessing its contributions and identifying gaps to enhance the understanding of RiMS’ role in contributing to these priorities and to inform the adaptation of strategic action plans to ensure alignment with global priorities.


Maureen T. Choman, MD

Latest:

Risks and Benefits of Disease-Modifying Therapies in People Aging With Multiple Sclerosis

More data are needed to ascertain the actual risks and benefits of DMT use, discontinuation, and de-escalation in older people with MS.


Rouven Brenner, MScN

Latest:

Nursing Interventions Focusing on Self-Efficacy for Patients With Multiple Sclerosis in Rehabilitation: A Systematic Review

"We encourage rehabilitation nurses from around the world to develop and distribute a comprehensive and generally accepted definition of rehabilitation nursing."









Sona Narula, MD

Latest:

Developing and Piloting a Dedicated Support Group for Young Adults With Multiple Sclerosis

Exposure to a dedicated young-adult virtual support group may provide a sense of normalcy, belonging, and validation and may give young adults the opportunity to interact and communicate with peers living with multiple sclerosis.




Marjorie Fitzsimmons, BS

Latest:

Ocrelizumab Wearing-Off Phenomenon: Prevalence, Predictors, and Outcomes After Intervention

Nearly 25% of people with multiple sclerosis in our study reported wearing off prior to their next ocrelizumab infusion while on the standard 6-month dosing interval.



Helmut Butzkueven, PhD, MBBS

Latest:

Migraine in Multiple Sclerosis: Underlying Mechanisms, Shared Symptoms, and Approaches to Management

Individuals with multiple sclerosis (MS) have a higher rate of migraine than the general population. Both conditions are associated with psychiatric comorbidity and cognitive symptoms that should be monitored given the potential for additive burden when MS and migraine co-occur.